Dr. Kumar Sharma, Department of Medicine, Division of Nephrology and Center for Renal Precision Medicine, and Dr. Subrata Debnath, Nephrology, are quoted in this news release disseminated on TD Ameritrade.com about NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury in COVID-19 patients.

Read story

The post TD Ameritrade: Can a vitamin treat COVID-19-related acute kidney injury? appeared first on UT Health San Antonio.